Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • FDA

    Tag: fda

    You Searched For "FDA"
    New Cochlear implant having safe access to MRI scans gets FDA nod

    New Cochlear implant having safe access to MRI scans gets FDA nod

    Deepanjana Sarkar19 Jun 2019 7:28 PM IST
    US Food and Drug Administration, FDA grants approval to a new Cochlear implant that has safe access during Magnetic Resonance Imaging.New Cochlear...
    Synthetic joint lubricant holds promise for osteoarthritis treatment

    Synthetic joint lubricant holds promise for osteoarthritis treatment

    Hina Zahid21 Jun 2019 7:25 PM IST
    ITHACA, N.Y. – A new type of treatment for osteoarthritis, currently in canine clinical trials, shows promise for eventual use in humans.The...
    Delafloxacin gets FDA priority review approval for community-acquired bacterial pneumonia

    Delafloxacin gets FDA priority review approval for community-acquired bacterial pneumonia

    Deepanjana Sarkar21 Jun 2019 7:20 PM IST
    The U.S Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for BAXDELA® (delafloxacin) for priority review....
    FDA approves BOTOX for upper limb spasticity in kids aged 2-17

    FDA approves BOTOX for upper limb spasticity in kids aged 2-17

    Deepanjana Sarkar23 Jun 2019 7:30 PM IST
    The US Food and Drug Administration (FDA) has announced the approval of BOTOX for the treatment of pediatric patients from 2-17 years of age with...
    FDA Issues Warning as Patient Dies after Receiving Fecal Microbiota Transplantation

    FDA Issues Warning as Patient Dies after Receiving Fecal Microbiota Transplantation

    Medha Baranwal Baranwal25 Jun 2019 7:10 PM IST
    Taking a cue from two cases whereby one immunocompromised patient died and second became infected after receiving fecal microbiota transplantation...
    FDA approves dupilumab for chronic rhinosinusitis with nasal polyps in adults

    FDA approves dupilumab for chronic rhinosinusitis with nasal polyps in adults

    Dr. Kamal Kant Kohli Kohli26 Jun 2019 7:27 PM IST
    Food and Drug Administration, FDA approves first nonsurgical treatment for inadequately controlled chronic rhinosinusitis with nasal polyps in adults....
    Empagliflozin gets FDA Fast-Track status for Chronic Heart Failure Treatment

    Empagliflozin gets FDA Fast-Track status for Chronic Heart Failure Treatment

    Deepanjana Sarkar28 Jun 2019 7:30 PM IST
    The U.S Food and Drug Administration has tagged sodium-glucose co-transporter 2 (SGLT2) inhibitor Empagliflozin with Fast-Tracked designation for the...
    Warning -- Antidepressants may trigger suicide attempts in adults with major depression

    Warning -- Antidepressants may trigger suicide attempts in adults with major depression

    Medha Baranwal Baranwal28 Jun 2019 7:25 PM IST
    New Delhi: The use of antidepressants significantly triggers suicide attempts in adults with major depression, finds a recent study published in the...
    FDA approves eculizumab as first treatment for neuromyelitis optica spectrum disorder

    FDA approves eculizumab as first treatment for neuromyelitis optica spectrum disorder

    Hina Zahid30 Jun 2019 7:20 PM IST
    FDA has approved Injection eculizumab as first treatment for neuromyelitis optica spectrum disorder.NMOSD is an autoimmune disease of the central...
    FDA releases new advice on fish consumption in pregnancy: Here is what you should know!

    FDA releases new advice on fish consumption in pregnancy: Here is what you should know!

    Medha Baranwal Baranwal2 July 2019 7:13 PM IST
    The US Food and Drug Administration (FDA) has revised advice that was issued by it, along with U.S. Environmental Protection Agency (EPA) regarding...
    FDA approves treatment for refractory multiple myeloma

    FDA approves treatment for refractory multiple myeloma

    Dr. Kamal Kant Kohli Kohli3 July 2019 7:15 PM IST
    FDA approves treatment for refractory multiple myeloma.The U.S. Food and Drug Administration (FDA)has granted accelerated approval to Xpovio...
    FDAs 1999 claim of soy as cholesterol lowering diet still valid, finds JAMA study

    FDA's 1999 claim of soy as cholesterol lowering diet still valid, finds JAMA study

    Medha Baranwal Baranwal4 July 2019 8:10 PM IST
    Canada: A recent study published in the JAMA journal has backed FDA's 1999 heart health claims of the cholesterol-lowering effect of soy protein,...
    PrevNext

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok